Jonathan S. Serody mainly focuses on Immunology, Graft-versus-host disease, Stem cell, CD8 and Immune system. His Immunology research includes themes of Hematopoietic stem cell transplantation and Transplantation. His Graft-versus-host disease study combines topics in areas such as Recombinant Granulocyte Colony-Stimulating Factor, Cytokine, Granulocyte macrophage colony-stimulating factor, Chemokine and Proinflammatory cytokine.
His work carried out in the field of Stem cell brings together such families of science as Pathology, Cell migration and Effector. His studies deal with areas such as Inflammasome, Adoptive cell transfer, Dendritic cell and Immunity as well as CD8. His Immune system study deals with Cytotoxic T cell intersecting with Cancer research, Immunotherapy and Melanoma.
His primary scientific interests are in Immunology, Graft-versus-host disease, Transplantation, T cell and Cancer research. His study looks at the relationship between Immunology and topics such as Stem cell, which overlap with Pathology. As a part of the same scientific study, Jonathan S. Serody usually deals with the Graft-versus-host disease, concentrating on Germinal center and frequently concerns with Ibrutinib.
His Transplantation research incorporates elements of Disease and Pathogenesis. His T cell research includes themes of Molecular biology and CD8. In his work, Oncology is strongly intertwined with Breast cancer, which is a subfield of Cancer research.
His primary areas of study are Cancer research, T cell, Graft-versus-host disease, Internal medicine and Immunology. His Cancer research study incorporates themes from Cancer immunotherapy, Immune system, CD19, Immunotherapy and Car t cells. His T cell research is multidisciplinary, incorporating elements of Cell, Priming, CD8 and Cell biology.
Jonathan S. Serody has included themes like Inflammation, Proinflammatory cytokine, Receptor, Dosing and Leukemia in his Graft-versus-host disease study. He interconnects Gastroenterology and Oncology in the investigation of issues within Internal medicine. His study on Immunology is mostly dedicated to connecting different topics, such as Transplantation.
His scientific interests lie mostly in Cancer research, Immunotherapy, T cell, Antigen and Extramural. His Cancer research research integrates issues from Receptor and In vivo. Immune system covers Jonathan S. Serody research in Immunotherapy.
His T cell research incorporates themes from Cell, Priming, CD8 and Cell biology. His work on Receptor expression is being expanded to include thematically relevant topics such as Graft-versus-host disease. His research integrates issues of Mucositis and Myeloid leukemia in his study of Graft-versus-host disease.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Bone marrow myeloid-derived suppressor cells (MDSCs) inhibit graft-versus-host disease (GVHD) via an arginase-1-dependent mechanism that is up-regulated by interleukin-13.
Steven L. Highfill;Paulo C. Rodriguez;Qing Zhou;Christine A. Goetz.
Antigen-capturing nanoparticles improve the abscopal effect and cancer immunotherapy.
Yuanzeng Min;Kyle C. Roche;Shaomin Tian;Michael J. Eblan.
Nature Nanotechnology (2017)
L-Selectinhi but not the L-selectinlo CD4+25+ T-regulatory cells are potent inhibitors of GVHD and BM graft rejection
Patricia A. Taylor;Angela Panoskaltsis-Mortari;Jessica M. Swedin;Philip J. Lucas.
Leukocyte migration and graft-versus-host disease
Christian A. Wysocki;Angela Panoskaltsis-Mortari;Bruce R. Blazar;Jonathan S. Serody.
In vitro–differentiated TH17 cells mediate lethal acute graft-versus-host disease with severe cutaneous and pulmonary pathologic manifestations
Michael J. Carlson;Michelle L. West;James M. Coghill;Angela Panoskaltsis-Mortari.
Intravascular Catheter Exchange and Duration of Candidemia
John H. Rex;John E. Bennett;Alan M. Sugar;Peter G. Pappas.
Clinical Infectious Diseases (1995)
Inhibition of acute graft-versus-host disease with retention of graft-versus-tumor effects by the proteasome inhibitor bortezomib
Kai Sun;Lisbeth A. Welniak;Angela Panoskaltsis-Mortari;Matthew J. O'Shaughnessy.
Proceedings of the National Academy of Sciences of the United States of America (2004)
Critical role for CCR5 in the function of donor CD4+CD25+ regulatory T cells during acute graft-versus-host disease
Christian A. Wysocki;Qi Jiang;Angela Panoskaltsis-Mortari;Patricia A. Taylor.
Genomic Analysis of Immune Cell Infiltrates Across 11 Tumor Types
Michael D. Iglesia;Joel S. Parker;Katherine A. Hoadley;Jonathan S. Serody.
Journal of the National Cancer Institute (2016)
Prognostic B-cell Signatures Using mRNA-Seq in Patients with Subtype-Specific Breast and Ovarian Cancer
Michael D. Iglesia;Benjamin G. Vincent;Joel S. Parker;Katherine A. Hoadley.
Clinical Cancer Research (2014)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: